Compare DuPont de Nemours Inc (DD) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DuPont de Nemours Inc vs Summit Therapeutics Inc — how do they compare? DuPont de Nemours Inc trades at $144.26 (market cap $19.51B), while Summit Therapeutics Inc trades at $15.5 (market cap $12.06B). The key difference: DuPont de Nemours Inc is the larger of the two by market cap, and DuPont de Nemours Inc pays a 1.66% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| DD | SMMT | |
|---|---|---|
Market Cap | $19.51B | $12.06B |
Sector | Basic Materials | Health |
52-Week High | $154.59 | $26.98 |
52-Week Low | $90.24 | $12.55 |
Enterprise Value | $20.90B | $11.39B |
Dividend Yield | 1.66% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DuPont de Nemours Inc
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
